血管内皮生长因子C(VEGFC)多克隆抗体

Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)

VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein

  • 血管内皮生长因子C(VEGFC)多克隆抗体产品包装(模拟)
  • 血管内皮生长因子C(VEGFC)多克隆抗体产品包装(模拟)
  • PAA145Bo01.jpgFigure. Western Blot; Sample: Recombinant VEGFC, Bovine.
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对VEGFC的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别VEGFC。

用法

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

赠品

相关产品

编号适用物种:Bos taurus; Bovine (Cattle,牛)应用(仅供研究使用,不用于临床诊断!)
RPA145Bo01血管内皮生长因子C(VEGFC)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
EPA145Bo61血管内皮生长因子C(VEGFC)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA145Bo01血管内皮生长因子C(VEGFC)多克隆抗体WB; IHC; ICC; IP.

参考文献

杂志参考文献
Journal of Cellular BiochemistryAlternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma[PubMed: 19241443]
genetics and molecular researchExpression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages[PubMed: 26125824]
Experimental and TherapeuticFenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia[PubMed: 26622498]
Am J PatholIL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages[PubMed: 26608451]
PLoS One.Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.[pubmed:27383632]
Oncology LettersRNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth andinduces apoptosis in mouse breast cancer in vitro and in vivo.[pubmed:27895746]
AngiogenesisCharacterization of isolated liver sinusoidal endothelial cells for liver bioengineering[Pubmed:29582235]
Oncology ReportsEffects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells[Pubmed:29328465]
LABORATORY INVESTIGATIONDynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease[Pubmed: 31019289]
Cutaneous and Ocular ToxicologyIsotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions?[Pubmed: 32722957]